Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29422613.
- Also identified by DOI 10.1038/s41467-018-02938-1 and PMC identifier 5805730.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tumors adapt their phenotypes during growth and in response to therapies through dynamic changes in cellular processes. Connexin proteins enable such dynamic changes during development, and their dysregulation leads to disease states. The gap junction communication channels formed by connexins have been reported to exhibit tumor-suppressive functions, including in triple-negative breast cancer (TNBC). However, we find that connexin 26 (Cx26) is elevated in self-renewing cancer stem cells (CSCs) and is necessary and sufficient for their maintenance. Cx26 promotes CSC self-renewal by forming a signaling complex with the pluripotency transcription factor NANOG and focal adhesion kinase (FAK), resulting in NANOG stabilization and FAK activation. This FAK/NANOG-containing complex is not formed in mammary epithelial or luminal breast cancer cells. These findings challenge the paradigm that connexins are tumor suppressors in TNBC and reveal a unique function for Cx26 in regulating the core self-renewal signaling that controls CSC maintenance.
Medical subject headings
- Cell Self Renewal
- Connexins
- Focal Adhesion Protein-Tyrosine Kinases
- Nanog Homeobox Protein
- Neoplastic Stem Cells
- Triple Negative Breast Neoplasms